ESC 365 - New insights on CETP inhibitors from genetic research and clinical trials

Open Access

New insights on CETP inhibitors from genetic research and clinical trials

Session: Role of CETP inhibitors in cardiovascular risk reduction: will lessons from the past lead to future success?

Topic: Lipid-Lowering Agents

Speaker: Professor J. Kastelein (Amsterdam, NL)

Sponsored by PACE-CME – Supported by an unrestricted educational grant from Menarini and NewAmsterdam Pharma

Event: ESC Congress 2023

Congress Presentation

Add to my library

About the speaker

Professor John Kastelein

Faculty of Medecine - University of Amsterdam, Amsterdam (Netherlands (The))

34 presentations

6 followers

4 more presentations in this session

Introduction

Speaker: Professor E. Stroes (Amsterdam, NL)

Unmet needs in lowering LDL-c: barriers to goal attainment and need for innovative targets

Speaker: Professor S. Nicholls (Melbourne, AU)

Exploring the role of novel CETP inhibitors in lipid management

Speaker: Professor R. Mehran (New York, US)

Discussion

Speaker: Professor E. Stroes (Amsterdam, NL) Professor S. Nicholls (Melbourne, AU) Professor J. Kastelein (Amsterdam, NL) Professor R. Mehran (New York, US)

Access the full session

Role of CETP inhibitors in cardiovascular risk reduction: will lessons from the past lead to future success?

Speakers: Professor J. Kastelein, Professor E. Stroes, Professor S. Nicholls, Professor R. Mehran, Professor E. Stroes...

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources